Record Information |
---|
Version | 2.0 |
---|
Created at | 2005-11-16 15:48:42 UTC |
---|
Updated at | 2024-09-17 15:41:09 UTC |
---|
NP-MRD ID | NP0000134 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Uridine diphosphate glucuronic acid |
---|
Description | Uridine diphosphate glucuronic acid is a nucleoside diphosphate sugar which serves as a source of glucuronic acid for polysaccharide biosynthesis. It may also be epimerized to UDP Iduronic acid, which donates Iduronic acid to polysaccharides. In animals, UDP glucuronic acid is used for formation of many glucosiduronides with various aglycones. The transfer of glucuronic acid from UDP-alpha-D-glucuronic acid onto a terminal galactose residue is done by beta1,3-glucuronosyltransferases, responsible for the completion of the protein-glycosaminoglycan linkage region of proteoglycans and of the HNK1 epitope of glycoproteins and glycolipids. In humans the enzyme galactose-beta-1,3-glucuronosyltransferase I completes the synthesis of the common linker region of glycosaminoglycans (GAGs) by transferring glucuronic acid (GlcA) onto the terminal galactose of the glycopeptide primer of proteoglycans. The GAG chains of proteoglycans regulate major biological processes such as cell proliferation and recognition, extracellular matrix deposition, and morphogenesis. (PMID: 16815917 ). |
---|
Structure | O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)O[C@H]([C@@H]1O)N1C=CC(=O)NC1=O InChI=1S/C15H22N2O18P2/c18-5-1-2-17(15(26)16-5)12-9(22)6(19)4(32-12)3-31-36(27,28)35-37(29,30)34-14-10(23)7(20)8(21)11(33-14)13(24)25/h1-2,4,6-12,14,19-23H,3H2,(H,24,25)(H,27,28)(H,29,30)(H,16,18,26)/t4-,6-,7+,8+,9-,10-,11+,12-,14-/m1/s1 |
---|
Synonyms | Value | Source |
---|
UDP-alpha-D-Glucuronate | ChEBI | UDP-D-Glucuronate | ChEBI | UDP-Glucuronate | ChEBI | UDPglucuronate | ChEBI | URIDINE-5'-diphosphATE-glucuronIC ACID | ChEBI | UDP-a-D-Glucuronate | Generator | UDP-a-D-Glucuronic acid | Generator | UDP-alpha-D-Glucuronic acid | Generator | UDP-Α-D-glucuronate | Generator | UDP-Α-D-glucuronic acid | Generator | UDP-D-Glucuronic acid | Generator | UDP-Glucuronic acid | Generator | UDPglucuronic acid | Generator | URIDINE-5'-diphosphate-glucuronate | Generator | URIDINE-5'-diphosphoric acid-glucuronic acid | Generator | Uridine diphosphate glucuronate | Generator | Uridine diphosphoric acid glucuronic acid | Generator | a-D-Glucopyranuronic acid 1->5'-ester with uridine 5'-(trihydrogen pyrophosphate) | HMDB | a-D-Glucopyranuronic acid ester with uridine 5'-pyrophosphate | HMDB | alpha-D-Glucopyranuronic acid 1-p'-ester with uridine 5'-(trihydrogen diphosphate) | HMDB | alpha-delta-Glucopyranuronic acid 1->5'-ester with uridine 5'-(trihydrogen pyrophosphate) | HMDB | alpha-delta-Glucopyranuronic acid 1-p'-ester with uridine 5'-(trihydrogen diphosphate) | HMDB | alpha-delta-Glucopyranuronic acid ester with uridine 5'-pyrophosphate | HMDB | Glucopyranuronic acid 1-ester with uridine 5'-pyrophosphate | HMDB | UDP Glucuronate | HMDB | UDP Glucuronic acid | HMDB | UDP-alpha-delta-Glucuronate | HMDB | UDP-delta-Glucuronate | HMDB | UDP-delta-Glucuronic acid | HMDB | UDP-GlcUA | HMDB | UDPGA | HMDB | UGA | HMDB | Uridine 5'-diphospho-a-D-glucuronate | HMDB | Uridine 5'-diphospho-a-D-glucuronic acid | HMDB | Uridine 5'-diphospho-alpha-delta-glucuronate | HMDB | Uridine 5'-diphospho-alpha-delta-glucuronic acid | HMDB | Uridine 5'-diphospho-glucuronic acid | HMDB | Uridine 5'-diphosphoglucuronate | HMDB | Uridine 5'-diphosphoglucuronic acid | HMDB | Uridine 5'-[3-(D-glucopyranosyloxyuronic acid) dihydrogen diphosphate] | HMDB | Uridine diphosphate-glucuronate | HMDB | Uridine diphospho-D-glucuronate | HMDB | Uridine diphospho-D-glucuronic acid | HMDB | Uridine diphospho-delta-glucuronate | HMDB | Uridine diphospho-delta-glucuronic acid | HMDB | Uridine diphosphoglucuronate | HMDB | Uridine diphosphoglucuronic acid | HMDB | Uridine pyrophosphoglucuronate | HMDB | Uridine pyrophosphoglucuronic acid | HMDB | Uridinediphosphoglucuronic acid | HMDB | Acid, UDP glucuronic | HMDB | Acid, uridine diphosphoglucuronic | HMDB | Glucuronic acid, UDP | HMDB | Diphosphoglucuronic acid, uridine | HMDB | Uridine 5'-diphospho-alpha-D-glucuronic acid | HMDB | Uridine 5'-diphospho-α-D-glucuronic acid | HMDB | Uridine 5’-diphospho-α-D-glucuronic acid | HMDB | Uridine 5’-diphosphoglucuronic acid | HMDB | Uridine diphosphate glucuronic acid | HMDB |
|
---|
Chemical Formula | C15H22N2O18P2 |
---|
Average Mass | 580.2853 Da |
---|
Monoisotopic Mass | 580.03428 Da |
---|
IUPAC Name | (2S,3S,4S,5R,6R)-6-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid |
---|
Traditional Name | udp-α-D-glucuronic acid |
---|
CAS Registry Number | 2616-64-0 |
---|
SMILES | O[C@@H]1[C@@H](COP(O)(=O)OP(O)(=O)O[C@H]2O[C@@H]([C@@H](O)[C@H](O)[C@H]2O)C(O)=O)O[C@H]([C@@H]1O)N1C=CC(=O)NC1=O |
---|
InChI Identifier | InChI=1S/C15H22N2O18P2/c18-5-1-2-17(15(26)16-5)12-9(22)6(19)4(32-12)3-31-36(27,28)35-37(29,30)34-14-10(23)7(20)8(21)11(33-14)13(24)25/h1-2,4,6-12,14,19-23H,3H2,(H,24,25)(H,27,28)(H,29,30)(H,16,18,26)/t4-,6-,7+,8+,9-,10-,11+,12-,14-/m1/s1 |
---|
InChI Key | HDYANYHVCAPMJV-LXQIFKJMSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as pyrimidine nucleotide sugars. These are pyrimidine nucleotides bound to a saccharide derivative through the terminal phosphate group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Nucleosides, nucleotides, and analogues |
---|
Class | Pyrimidine nucleotides |
---|
Sub Class | Pyrimidine nucleotide sugars |
---|
Direct Parent | Pyrimidine nucleotide sugars |
---|
Alternative Parents | |
---|
Substituents | - Pyrimidine nucleotide sugar
- Pyrimidine ribonucleoside diphosphate
- Pentose phosphate
- Pentose-5-phosphate
- Glucuronic acid or derivatives
- Glycosyl compound
- N-glycosyl compound
- Monosaccharide phosphate
- Organic pyrophosphate
- Beta-hydroxy acid
- Monoalkyl phosphate
- Pyrimidone
- Hydropyrimidine
- Hydroxy acid
- Monosaccharide
- Organic phosphoric acid derivative
- Oxane
- Phosphoric acid ester
- Pyran
- Pyrimidine
- Alkyl phosphate
- Tetrahydrofuran
- Vinylogous amide
- Heteroaromatic compound
- Secondary alcohol
- Urea
- Lactam
- Carboxylic acid derivative
- Carboxylic acid
- Azacycle
- Oxacycle
- Organoheterocyclic compound
- Monocarboxylic acid or derivatives
- Polyol
- Organooxygen compound
- Alcohol
- Organic oxygen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Organopnictogen compound
- Organic oxide
- Carbonyl group
- Organonitrogen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Ghosal A, Hapangama N, Yuan Y, Achanfuo-Yeboah J, Iannucci R, Chowdhury S, Alton K, Patrick JE, Zbaida S: Identification of human UDP-glucuronosyltransferase enzyme(s) responsible for the glucuronidation of ezetimibe (Zetia). Drug Metab Dispos. 2004 Mar;32(3):314-20. [PubMed:14977865 ]
- Quintus J, Kovar KA, Link P, Hamacher H: Urinary excretion of arbutin metabolites after oral administration of bearberry leaf extracts. Planta Med. 2005 Feb;71(2):147-52. [PubMed:15729623 ]
- Cappiello M, Giuliani L, Rane A, Pacifici GM: Uridine 5'-diphosphoglucuronic acid (UDPGLcUA) in the human fetal liver, kidney and placenta. Eur J Drug Metab Pharmacokinet. 2000 Jul-Dec;25(3-4):161-3. [PubMed:11420884 ]
- Huskey SW, Doss GA, Miller RR, Schoen WR, Chiu SH: N-glucuronidation reactions. II. Relative N-glucuronidation reactivity of methylbiphenyl tetrazole, methylbiphenyl triazole, and methylbiphenyl imidazole in rat, monkey, and human hepatic microsomes. Drug Metab Dispos. 1994 Jul-Aug;22(4):651-8. [PubMed:7956743 ]
- Alkharfy KM, Frye RF: High-performance liquid chromatographic assay for acetaminophen glucuronide in human liver microsomes. J Chromatogr B Biomed Sci Appl. 2001 Apr 5;753(2):303-8. [PubMed:11334344 ]
- Hagenauer B, Salamon A, Thalhammer T, Kunert O, Haslinger E, Klingler P, Senderowicz AM, Sausville EA, Jager W: In vitro glucuronidation of the cyclin-dependent kinase inhibitor flavopiridol by rat and human liver microsomes: involvement of UDP-glucuronosyltransferases 1A1 and 1A9. Drug Metab Dispos. 2001 Apr;29(4 Pt 1):407-14. [PubMed:11259324 ]
- Cappiello M, Giuliani L, Pacifici GM: Distribution of UDP-glucuronosyltransferase and its endogenous substrate uridine 5'-diphosphoglucuronic acid in human tissues. Eur J Clin Pharmacol. 1991;41(4):345-50. [PubMed:1804651 ]
- Fondeur-Gelinotte M, Lattard V, Oriol R, Mollicone R, Jacquinet JC, Mulliert G, Gulberti S, Netter P, Magdalou J, Ouzzine M, Fournel-Gigleux S: Phylogenetic and mutational analyses reveal key residues for UDP-glucuronic acid binding and activity of beta1,3-glucuronosyltransferase I (GlcAT-I). Protein Sci. 2006 Jul;15(7):1667-78. [PubMed:16815917 ]
- (). Clinical Guide to Laboratory Tests, 2nd Ed. Norbert W. Tietz 1990. .
|
---|